Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Research last month suggested that starting GLP-1 receptor agonist treatment in people with epilepsy and type 2 diabetes was ...

With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.

The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...

Pfizer has entered into a global collaboration and license agreement with YaoPharma for the development, manufacturing and commercialization of YP05002, a small-molecule GLP-1 receptor agonist ...

The Chinese biotech evaluated three different once-daily doses of its oral GLP-1 agonist, dubbed ASC30, in a phase 2 study of ...

True or False: A large observational study found that adults with diabetes who used GLP-1 receptor agonists had more ...